Varex Imaging Corporation
NASDAQ:VREXMedical - Devices
+$0.34 today
- Market cap
- $770.71M
- Beta
- 0.90
- P/E (TTM)
- -5.3
- EPS (TTM)
- -$1.97
Volume 0.73M
Average 0.36M
VREX Other Financing Activities
Financing cash flows not reported separately.
Varex Imaging CorporationNASDAQ: VREX
Other Financing Activities · Q2 FY2026 · quarter ended Apr 2026
Other financing activities growth accelerates
Q2 FY2026 other financing activities of $7.8M (cash outflow) rose 2500.0% year over year, ahead of the +1000.0% change in trailing-twelve-month other financing activities. Sequentially, it rose 7700.0% from the prior quarter.
Context
- Other financing activities amounted to 0.5% of revenue in FY2025, up 0.3 pp from a year earlier.
- Other financing activities increased in 0 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +2500.0% holds above the trailing-twelve-month pace of +1000.0%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Other Financing Activities history
USD · from the cash flow
- Latest · FY2025
- (4.2M) USD
- Year-over-year change
- -147.1%
| Period | Period end | Other Financing Activities | YoY change |
|---|---|---|---|
| FY2025 | 2025-10-03 | (4.2M) | -147.1% |
| FY2024 | 2024-09-27 | (1.7M) | -177.3% |
| FY2023 | 2023-09-29 | 2.2M | -60.7% |
| FY2022 | 2022-09-30 | 5.6M | +900.0% |
| FY2021 | 2021-10-01 | (700K) | — |
Other Financing Activities vs competitors
How VREX compares with its peers on the latest reported figures
- VREX's LTM Apr 2026 other financing activities of $8.8M is the 4th largest of the 5 companies compared; the peer median is $15.53M.
- Its year-over-year change of +1000.0% is the 3rd highest of 5, against a peer median of +2293.2%.
- Other financing activities amounts to 1.0% of revenue for VREX, versus a peer median of 10.6%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $670.1M | +4508.6% | -10.2% | 19.1% | |
| LTM Jun 2026 | $313M | +61.3% | -76.1% | 1.5% | |
| LTM Jun 2026 | $36.88M | +77.8% | — | 2.1% | |
| LTM Apr 2026 | $8.8M | +1000.0% | — | 1.0% | |
| LTM Dec 2025 | $5.82M | +10455.5% | — | 44.7% | |
| Peer median (excluding VREX) | $15.53M | +2293.2% | -43.2% | 10.6% | |
Competitors are the stored peer set for VREX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Oct 2021 | FY2022 Sep 2022 | FY2023 Sep 2023 | FY2024 Sep 2024 | FY2025 Oct 2025 |
|---|---|---|---|---|---|
| Net Income | 17.9M | 30.8M | 48.7M | (47.2M) | (69.9M) |
| Depreciation & Amortization | 37.3M | 33.6M | 33.2M | 31.1M | 27.2M |
| Deferred Income Tax | (3M) | 600K | (39.5M) | 37M | (500K) |
| Stock-Based Compensation | 13.9M | 14M | 13.5M | 15.3M | 15M |
| Change in Working Capital | 8.2M | (88M) | 23.3M | 2M | (31.4M) |
| Accounts Receivables | (32.9M) | (18.1M) | 9.8M | 6.7M | 100K |
| Inventory | 42.8M | (85M) | 20.2M | 6.6M | (39.9M) |
| Accounts Payables | (13.6M) | 19.7M | (15M) | (3.2M) | 6.2M |
| Other Working Capital | 11.9M | (4.6M) | 8.3M | (8.1M) | 2.2M |
| Other Non-Cash Items | 18.3M | 25.9M | 29.2M | 9.1M | 101.3M |
| Operating Cash Flow | 92.6M | 16.9M | 108.4M | 47.3M | 41.7M |
| Capital Expenditures | (15.1M) | (21.3M) | (20.7M) | (26.9M) | (22.9M) |
| Acquisitions (Net) | (1.4M) | 1.1M | (1M) | 900K | 0 |
| Purchases of Investments | 0 | (28.3M) | (55.9M) | (61M) | (31.4M) |
| Sales of Investments | 0 | 2M | 28.3M | 60.6M | 65.4M |
| Other Investing Activities | 300K | (1.9M) | 4.4M | (1.1M) | (800K) |
| Investing Cash Flow | (16.2M) | (48.4M) | (44.9M) | (27.5M) | 10.3M |
| Debt Repayment | (31.6M) | (29.4M) | (2.4M) | (1.6M) | (75M) |
| Common Stock Issued | 0 | 0 | 0 | 0 | 3.3M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (700K) | 5.6M | 2.2M | (1.7M) | (4.2M) |
| Financing Cash Flow | (32.3M) | (23.8M) | (200K) | (3.3M) | (75.9M) |
| Effect of Forex Changes | (100K) | (200K) | 100K | (100K) | 600K |
| Net Change in Cash | 44M | (55.5M) | 63.4M | 16.4M | (23.3M) |
| Free Cash Flow | 77.5M | (4.4M) | 87.7M | 20.4M | 18.8M |
Varex Imaging Corporation
NASDAQ:VREX
Intrinsic Alpha fair value
Locked
Current Price
$18.15
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.